Granted Patent
B2
US 11,155,563 · App. 17/213,093 · Granted Oct 26, 2021
Macrocyclic compounds and uses thereof
Inventors:
Jingrong Jean Cui (San Diego, CA); Evan W. Rogers (San Diego, CA); Jane Ung (San Diego, CA); Jeffrey Whitten (San Diego, CA); Dayong Zhai (San Diego, CA); Wei Deng (San Diego, CA); Xin Zhang (San Diego, CA); Zhongdong Huang (San Diego, CA); Jing Liu (San Diego, CA); Han Zhang (San Diego, CA)
Assignee:
Turning Point Therapeutics, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The present disclosure relates to certain macrocyclic compounds that inhibit SRC and MET, and/or CSF1R, pharmaceutical compositions containing such compounds, and methods of using such compounds to treat cancer.
Claims (5)
1. A compound having structure:
or a pharmaceutically acceptable salt thereof.
2. A compound having structure:
3. A pharmaceutical composition comprising a compound having structure:
or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable diluent, carrier or excipient.
Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jun 30, 2021
From: CUI, JINGRONG JEAN; ROGERS, EVAN W.; UNG, JANE; WHITTEN, JEFFREY; ZHAI, DAYONG; DENG, WEI; ZHANG, XIN; HUANG, ZHONGDONG; LIU, JING; ZHANG, HAN
To: TURNING POINT THERAPEUTICS, INC.
Reel/Frame 056724/0262 →
Continuity (4)
Continuation
16634289
Provisional Application
62700990
· Jul 20, 2018
Provisional Application
62538193
· Jul 28, 2017
Cited By (1)